H.H. Hirsch

Discipline

Sociologie (2) Economies et finances (2) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (23) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Swiss (16) Patients (14) Human beings (14) Patients (14) cohorte (14) Treatment (12) temps (durée) (9) Time (9) virus (8) thérapie (8) Ci (Chinese poetry) (8) Therapeutics (8) Confidence (8) Older people (8) Use (8) infection (7) adulte (7) Methods (7) Infection (7) Methods (7) adulte (7) association (6) analyse (6) Social groups (6) Analysis (6) Models (6) recherche (5) organe (5) modèle (5) effet (5)

Documents écrit par H.H. Hirsch (23) | parle de H.H. Hirsch (0)

The Swiss Pathogen Surveillance Platform - towards a nation-wide One Health data exchange platform for bacterial, viral and fungal genomics and associated metadata.
A. Neves et al.
The EHA Research Roadmap: Infections in Hematology.
C. Cordonnier et al.
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
B. Speich et al. (21 oct. 2021)
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study.
L.N. Walti et al.
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link.
H. Nguyen et al. (1 juin 2021)
SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021-Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing.
A.R. Goncalves Cabecinhas et al. (25 mars 2021)
Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance
A. Mari et al. (2021)
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
J. Tschopp et al.
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations
C. Marzolini et al. (2020)
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect
F. Stader et al. (2020)
Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.
P.W. Schreiber et al. (2018)
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.
T. Turk et al. (12 sept. 2017)
Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro.
A. Tschan-Plessl et al.
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland.
M. Shilaih et al. (14 juin 2016)
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study : changes in treatment uptake and outcomes between 1991 and 2013
G. Wandeler et al. (2015)
Increases in condomless sex in the Swiss HIV Cohort Study.
R.D. Kouyos et al. (2015)
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.
A. Wójtowicz et al. (2015)
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation.
O. Manuel et al. (2015)
Obesity trends and body mass index changes after starting antiretroviral treatment : the Swiss HIV Cohort Study
B. Hasse et al. (2014)
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.
J. Fehr et al. (2011)
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
S. Jilek et al. (2010)
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
N. Khanna et al. (2009)
HIV and solid organ transplantation: the Swiss experience.
N.J. Müller et al. (18 mars 2006)